Recent Finacing
Recent Raise
Ablaze Pharmaceuticals is a clinical-stage pharma company developing and commercializing targeted radiopharmaceutical therapies for solid tumors, building a TRT pipeline and holding exclusive Greater China rights to RayzeBio products.
